FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308187424> ?p ?o ?g. }

• W4308187424 endingPage "101144" @default.
• W4308187424 startingPage "101144" @default.
• W4308187424 abstract "Coronavirus-2019 (COVID-19) is known to affect the heart and is associated with a pro-inflammatory state. Most studies to date have focused on clinically sick subjects. Here, we report cardiac and proinflammatory biomarkers levels in ambulatory young adults with asymptomatic or mild COVID-19 infection compared to those without infection 4–8 weeks after severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) testing. 131 asymptomatic or mildly symptomatic subjects were enrolled following testing for SARS-COV-2. Fifty subjects tested negative, and 81 subjects tested positive. Serum samples were collected for measurement of C-reactive protein, ferritin, interleukin-6, NT-pro-B-type natriuretic peptide, and cardiac troponin 28–55 days after SARS-COV-2 RT-PCR testing. Biomarker levels trended higher in SARS-COV-2-positive vs negative subjects, but differences in biomarker levels or proportion of subjects with elevated biomarkers were not statistically significant with respect to SARS-COV-2 status. Among individuals with ≥ 1 comorbidity, odds of elevated CRP were greater compared to individuals without any comorbidities (odds ratio [OR] = 2.90); this effect size was increased 1.4-fold among SARS-COV-2-positive subjects (OR = 4.03). Similarly, NT-pro-BNP was associated with CVD, with the strongest association in COVID-positive individuals (OR = 16.9). In a relatively young, healthy adult population, mild COVID-19 infection was associated with mild elevations in cardiac and proinflammatory biomarkers within 4–8 weeks of mild or asymptomatic COVID-19 infection in individuals with preexisting comorbidities, but not among individuals without comorbidities. For the general population of young adults, we did not find evidence of elevation of cardiac or proinflammatory biomarkers 4–8 weeks after COVID-19 infection. Clinical Perspective: This is a characterization of cardiac and proinflammatory biomarkers in ambulatory subjects following asymptomatic or mild COVID-19 infection. Young, ambulatory individuals did not have cardiac and proinflammatory biomarker elevation 4–8 weeks after mild COVID-19 infection. However, COVID-19 infection was associated with biomarker elevations in select individuals with comorbidities. Clinical study number: H-47423." @default.
• W4308187424 created "2022-11-09" @default.
• W4308187424 creator A5000609088 @default.
• W4308187424 creator A5011782005 @default.
• W4308187424 creator A5039683052 @default.
• W4308187424 creator A5061988295 @default.
• W4308187424 creator A5073154637 @default.
• W4308187424 creator A5077804406 @default.
• W4308187424 creator A5089864107 @default.
• W4308187424 date "2022-12-01" @default.
• W4308187424 modified "2023-10-16" @default.
• W4308187424 title "Abnormalities in cardiac and inflammatory biomarkers in ambulatory subjects after COVID-19 infection" @default.
• W4308187424 cites W1973386605 @default.
• W4308187424 cites W1974718993 @default.
• W4308187424 cites W1989231226 @default.
• W4308187424 cites W2008414119 @default.
• W4308187424 cites W2025353591 @default.
• W4308187424 cites W2069251038 @default.
• W4308187424 cites W2117384669 @default.
• W4308187424 cites W2131110345 @default.
• W4308187424 cites W2165890913 @default.
• W4308187424 cites W2415715899 @default.
• W4308187424 cites W2617626520 @default.
• W4308187424 cites W2759991334 @default.
• W4308187424 cites W2782429853 @default.
• W4308187424 cites W2898992716 @default.
• W4308187424 cites W3012180666 @default.
• W4308187424 cites W3024108905 @default.
• W4308187424 cites W3031456278 @default.
• W4308187424 cites W3034313907 @default.
• W4308187424 cites W3035340743 @default.
• W4308187424 cites W3036155640 @default.
• W4308187424 cites W3043297876 @default.
• W4308187424 cites W3045277594 @default.
• W4308187424 cites W3084486385 @default.
• W4308187424 cites W3089650891 @default.
• W4308187424 cites W3092612971 @default.
• W4308187424 cites W3093426014 @default.
• W4308187424 cites W3118645514 @default.
• W4308187424 cites W3128466001 @default.
• W4308187424 cites W3129880731 @default.
• W4308187424 cites W3136071389 @default.
• W4308187424 cites W3136866748 @default.
• W4308187424 cites W3137946873 @default.
• W4308187424 cites W3187425005 @default.
• W4308187424 cites W3191809995 @default.
• W4308187424 cites W3197096949 @default.
• W4308187424 cites W3217165823 @default.
• W4308187424 cites W4211233178 @default.
• W4308187424 cites W4220778576 @default.
• W4308187424 cites W4220925428 @default.
• W4308187424 cites W4288058923 @default.
• W4308187424 doi "https://doi.org/10.1016/j.ijcha.2022.101144" @default.
• W4308187424 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36321063" @default.
• W4308187424 hasPublicationYear "2022" @default.
• W4308187424 type Work @default.
• W4308187424 citedByCount "1" @default.
• W4308187424 countsByYear W43081874242023 @default.
• W4308187424 crossrefType "journal-article" @default.
• W4308187424 hasAuthorship W4308187424A5000609088 @default.
• W4308187424 hasAuthorship W4308187424A5011782005 @default.
• W4308187424 hasAuthorship W4308187424A5039683052 @default.
• W4308187424 hasAuthorship W4308187424A5061988295 @default.
• W4308187424 hasAuthorship W4308187424A5073154637 @default.
• W4308187424 hasAuthorship W4308187424A5077804406 @default.
• W4308187424 hasAuthorship W4308187424A5089864107 @default.
• W4308187424 hasBestOaLocation W43081874242 @default.
• W4308187424 hasConcept C126322002 @default.
• W4308187424 hasConcept C156957248 @default.
• W4308187424 hasConcept C164027704 @default.
• W4308187424 hasConcept C185592680 @default.
• W4308187424 hasConcept C203014093 @default.
• W4308187424 hasConcept C2776914184 @default.
• W4308187424 hasConcept C2777910003 @default.
• W4308187424 hasConcept C2778319317 @default.
• W4308187424 hasConcept C2779159551 @default.
• W4308187424 hasConcept C2781197716 @default.
• W4308187424 hasConcept C2908647359 @default.
• W4308187424 hasConcept C30036603 @default.
• W4308187424 hasConcept C35785553 @default.
• W4308187424 hasConcept C55493867 @default.
• W4308187424 hasConcept C71924100 @default.
• W4308187424 hasConcept C90924648 @default.
• W4308187424 hasConcept C99454951 @default.
• W4308187424 hasConceptScore W4308187424C126322002 @default.
• W4308187424 hasConceptScore W4308187424C156957248 @default.
• W4308187424 hasConceptScore W4308187424C164027704 @default.
• W4308187424 hasConceptScore W4308187424C185592680 @default.
• W4308187424 hasConceptScore W4308187424C203014093 @default.
• W4308187424 hasConceptScore W4308187424C2776914184 @default.
• W4308187424 hasConceptScore W4308187424C2777910003 @default.
• W4308187424 hasConceptScore W4308187424C2778319317 @default.
• W4308187424 hasConceptScore W4308187424C2779159551 @default.
• W4308187424 hasConceptScore W4308187424C2781197716 @default.
• W4308187424 hasConceptScore W4308187424C2908647359 @default.
• W4308187424 hasConceptScore W4308187424C30036603 @default.
• W4308187424 hasConceptScore W4308187424C35785553 @default.
• W4308187424 hasConceptScore W4308187424C55493867 @default.

• next